Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. (Q54354561)

28 May 2018

title

Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. (English)

1 reference

28 May 2018

author

Jimena Giudice

4

1 reference

28 May 2018

Elba Vazquez

object named as

E Vazquez

12

0 references

Arghavan Salles

5

object named as

A Salles

1 reference

28 May 2018

author name string

M Ferrando

1

1 reference

28 May 2018

G Gueron

2

1 reference

28 May 2018

B Elguero

3

1 reference

28 May 2018

F Coluccio Leskow

6

1 reference

28 May 2018

E A Jares-Erijman

7

1 reference

28 May 2018

L Colombo

8

1 reference

28 May 2018

R Meiss

9

1 reference

28 May 2018

N Navone

10

1 reference

28 May 2018

A De Siervi

11

1 reference

28 May 2018

publication date

11 August 2011

1 reference

28 May 2018

published in

Angiogenesis

1 reference

28 May 2018

volume

14

1 reference

28 May 2018

issue

4

1 reference

28 May 2018

page(s)

467-479

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s10456-011-9230-4

exact match

0 references

cites work

Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Vasculogenensis, angiogenesis and special features of tumor blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Heme oxygenase-1 in tumors: is it a false friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Inhale to survive, cycle or die? Carbon monoxide and cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Angiogenesis: an organizing principle for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Targeting integrins for the control of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Integrin and growth factor receptor crosstalk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

The role of hypoxia-inducible factors in tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Different mechanisms lead to the angiogenic process induced by three adenocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

NF-kappa B activation as a pathological mechanism of septic shock and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Signalling pathways in prostate carcinogenesis: potentials for molecular-targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Targeting the growth factors and angiogenesis pathways: small molecules in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Oxidative stress in tumor angiogenesis- therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Tumor growth and angiogenesis is impaired in CIB1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Heme oxygenase-1 system and gastrointestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Tumor progression: defining the soil round the tumor seed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Metastatic properties of prostate cancer cells are controlled by VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Chemokines and Cancer: A Fatal Attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9230-4

10.1007/S10456-011-9230-4

21 January 2018

Identifiers

DOI

1 reference

28 May 2018

PubMed ID

21833623

1 reference

28 May 2018